Immunovant (IMVT) Total Current Liabilities (2018 - 2026)
Immunovant's Total Current Liabilities came in at $117.1 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 121.4% from $52.9 million a year earlier and up 12.1% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Total Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant's Total Current Liabilities was $104.42 million, up 51.8% from FY2025.
- Total Current Liabilities has increased in each of the last three fiscal years, with a five-year compound annual growth rate of 40.9% (FY2021 to FY2026).
- Going back by fiscal year, Total Current Liabilities was $68.78 million in FY2025 (+41.5%), $48.61 million in FY2024 (+12.3%), $43.3 million in FY2023 (-2.7%) and $44.52 million in FY2022 (+137.2%).
- The fiscal Q1 2027 figure represents the highest quarterly Total Current Liabilities in data going back to fiscal Q3 2019.
- Year-over-year, Total Current Liabilities increased in six of the last eight quarters, with growth averaging 50.3%.
- The fastest year-over-year change in Total Current Liabilities over five years came in fiscal Q1 2024 (growth of 141.7%), and the weakest in fiscal Q3 2024 (a decline of 22.2%).
- Business Quant data shows IMVT's Total Current Liabilities at $104.42 million (Q4 2026), $66.26 million (Q3 2026) and $63.25 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 117.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.10 Mn |
| Mar 31, 2026 | 104.42 Mn |
| Dec 31, 2025 | 66.26 Mn |
| Sep 30, 2025 | 63.25 Mn |
| Jun 30, 2025 | 52.90 Mn |
| Mar 31, 2025 | 68.78 Mn |
| Dec 31, 2024 | 68.32 Mn |
| Sep 30, 2024 | 66.65 Mn |
| Jun 30, 2024 | 45.02 Mn |
| Mar 31, 2024 | 48.61 Mn |
| Dec 31, 2023 | 32.10 Mn |
| Sep 30, 2023 | 40.26 Mn |
| Jun 30, 2023 | 51.36 Mn |
| Mar 31, 2023 | 43.30 Mn |
| Dec 31, 2022 | 41.26 Mn |
| Sep 30, 2022 | 31.78 Mn |
| Jun 30, 2022 | 21.24 Mn |
| Mar 31, 2022 | 44.52 Mn |
| Dec 31, 2021 | 36.35 Mn |
| Sep 30, 2021 | 28.38 Mn |
API Access
Immunovant Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();